A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays

被引:114
作者
Farshad, A
Burg, G
Panizzon, R
Dummer, R
机构
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[2] CHU Vaudois, Serv Dermatol, CH-1011 Lausanne, Switzerland
关键词
lentigo maligna; lentigo maligna melanoma; radiotherapy; recurrence rate; skin tumours;
D O I
10.1046/j.1365-2133.2002.04750.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Lentigo maligna (LM) and lentigo maligna melanoma (LMM) are the most common melanocytic neoplasms on sun-exposed skin of elderly patients. Objectives To perform a retrospective study of 150 patients with LM and LMM treated with radiotherapy using Grenz or soft X-rays. Methods The information recorded and analysed included gender, age, diagnosis, size of the lesion, localization, X-ray treatment, recurrence rate, other skin malignancies and non-dermatological neoplasms. Results The 150 patients comprised 78 women and 72 men (mean age 70 years). Ninety-three patients had LM, 54 had LMM and three had both neoplasms. Ninety per cent of lesions were located on the face. Treatment was with Grenz rays in 96 patients with LM and 11 with LMM (70%) and with soft X-rays in 46 patients with LMM (30%). Three patients were treated using both modalities. One hundred and one patients were followed up for at least 2 years after radiotherapy (mean 8 years). The mean time to recurrence was 45.6 months, and the recurrence rate was 7% (seven of 101). Other skin malignancies were observed in 65 of 150 patients, including basal cell carcinoma in 23 (35%) and actinic keratosis in 20 (31%). Four patients developed internal cancers. Conclusions The study showed that radiotherapy of LM and LMM was curative. In particular, radiotherapy proved to be an excellent treatment for elderly patients. Owing to the high incidence of other skin cancers, LM patients need careful follow-up.
引用
收藏
页码:1042 / 1046
页数:5
相关论文
共 24 条
[1]  
BARNHILL RL, 1993, SEMIN DIAGN PATHOL, V10, P47
[2]  
CLARK WH, 1969, AM J PATHOL, V55, P39
[3]   TREATMENT OF LENTIGO MALIGNA AND LENTIGO MALIGNA MELANOMA [J].
COLEMAN, WP ;
DAVIS, RS ;
REED, RJ ;
KREMENTZ, ET .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1980, 6 (06) :476-479
[4]   Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck [J].
Cox, NH ;
Aitchison, TC ;
Sirel, JM ;
MacKie, RM .
BRITISH JOURNAL OF CANCER, 1996, 73 (07) :940-944
[5]  
DANCUART F, 1980, CANCER, V45, P2279, DOI 10.1002/1097-0142(19800501)45:9<2279::AID-CNCR2820450910>3.0.CO
[6]  
2-H
[7]   RADIATION-THERAPY FOR MELANOMAS OF THE HEAD AND NECK [J].
HARWOOD, AR ;
LAWSON, VG .
HEAD & NECK SURGERY, 1982, 4 (06) :468-474
[8]   RADIOTHERAPY FOR MALIGNANT-MELANOMA - A REAPPRAISAL [J].
HARWOOD, AR ;
CUMMINGS, BJ .
CANCER TREATMENT REVIEWS, 1981, 8 (04) :271-282
[9]   CONVENTIONAL FRACTIONATED RADIOTHERAPY FOR 51 PATIENTS WITH LENTIGO MALIGNA AND LENTIGO MALIGNA MELANOMA [J].
HARWOOD, AR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1983, 9 (07) :1019-1021
[10]   FOLLOWING LENTIGO MALIGNA MAY NOT PREVENT THE DEVELOPMENT OF LIFE-THREATENING MELANOMA [J].
KELLY, JW .
ARCHIVES OF DERMATOLOGY, 1992, 128 (05) :657-660